Xencor, Inc. (XNCR) - NASDAQ
Company Description
Xencor, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. The company uses proprietary XmAb technology platform to create next-generation... More
Sector: Healthcare
Industry: Diagnostic Substances
Country: United States